Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 8
Submit an article Journal homepage
341
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates

Clive S. ZentDivision of HematologyCorrespondence[email protected]
,
Timothy G. CallDivision of Hematology
,
Deborah A. BowenDivision of Hematology
,
Michael J. ConteDivision of Hematology
,
Betsy R. LaPlantDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
,
Thomas E. WitzigDivision of Hematology
,
Stephen M. AnsellDivision of Hematology
&
George J. WeinerHolden Comprehensive Cancer Center and Department of Internal Medicine, University of Iowa, Iowa City, IA, USA
 show all
Pages 2373-2378 | Received 15 Nov 2014, Accepted 03 Feb 2015, Published online: 17 Mar 2015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.